🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.6749
-0.0863 (-11.34%)
At close: Nov 19, 2026, 4:00 PM EST
0.7500
+0.0751 (11.13%)
After-hours: Nov 19, 2026, 4:42 PM EST

NMTC Stock Forecast

NMTC's stock price has decreased by -82.42% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, NMTC stock has a consensus rating of "Strong Buy" and an average price target of $7.27. The average 1-year stock price forecast is 976.75% higher than the current stock price, while the lowest is $5.00 (+640.85%) and the highest is $8.80 (+1,203.90%).

Price Target: $7.27 (+976.75%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$7.27$8.00$8.80
Change+640.85%+976.75%+1085.4%+1203.9%
* Price targets were last updated on Oct 7, 2026.

Analyst Ratings

The average analyst rating for NMTC stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Aug '26Oct '26Nov '26
Strong Buy222222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Reiterates
$5
BuyReiterates$5+640.85%Oct 7, 2026
JonesTrading
JonesTrading
Buy
Reiterates
$8
BuyReiterates$8+1,085.36%Aug 18, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Reiterates
$8.8
BuyReiterates$8.8+1,203.90%Aug 14, 2026

Financial Forecast

Revenue This Year
10.26M
from 12.10M
Decreased by -15.15%
Revenue Next Year
12.83M
from 10.26M
Increased by 25.00%
EPS This Year
-1.08
EPS Next Year
n/a
from -1.08
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
242.96K2.12M3.41M3.45M12.10M10.26M
Revenue Growth
-87.39%772.60%60.73%1.33%250.35%-15.15%
Operating Income
-10.22M-10.03M-11.96M-11.89M-4.23M-8.41M
Net Income
-9.95M-10.00M-11.86M-12.32M-3.61M-7.59M
EPS
------1.08
Free Cash Flow
------10.01M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.5M
Avg10.3M
Low10.0M

Revenue Growth

Revenue Growth202620272028
High
-13.0%
Avg
-15.2%
Low
-17.3%

EPS Forecast

EPS202620272028
High-1.08
Avg-1.08
Low-1.08

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-